Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Al-Samkari

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Journal of Blood Medicine|October 1, 2019
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver diseaseAbraham Z Cheloff, Hanny Al-Samkari
British Journal of Haematology|September 6, 2019
Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet countHanny Al-Samkari, David J Kuter
British Journal of Haematology|March 5, 2025
Chemotherapy-induced thrombocytopenia: modern diagnosis and treatmentAndrew B Song, Hanny Al-Samkari
Therapeutic Advances in Hematology|January 6, 2022
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemiasHanny Al-Samkari, Eduard J van Beers
The New England Journal of Medicine|February 18, 2026
Engasertib in Hereditary Hemorrhagic Telangiectasia. ReplyHanny Al-Samkari, Damien Picard, Hans-Jurgen Mager
Haematologica|May 26, 2018
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspectiveAthena Kritharis, Hanny Al-Samkari, David J Kuter
Cancers|July 26, 2020
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer PatientsOrly Leiva, Jean M Connors, Hanny Al-Samkari
Annals of Internal Medicine|September 13, 2021
Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case ReportHanny Al-Samkari, Rebecca Karp Leaf, Katayoon Goodarzi
The New England Journal of Medicine|June 3, 2026
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. ReplyHanny Al-Samkari, Kejia Wang, Gerald A Soff
Pediatric Blood & Cancer|December 28, 2021
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trialsNardeen Ayad, Rachael F Grace, Hanny Al-Samkari
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Journal of Blood Medicine|October 1, 2019
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver diseaseAbraham Z Cheloff, Hanny Al-Samkari
British Journal of Haematology|September 6, 2019
Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet countHanny Al-Samkari, David J Kuter
British Journal of Haematology|March 5, 2025
Chemotherapy-induced thrombocytopenia: modern diagnosis and treatmentAndrew B Song, Hanny Al-Samkari
Therapeutic Advances in Hematology|January 6, 2022
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemiasHanny Al-Samkari, Eduard J van Beers
The New England Journal of Medicine|February 18, 2026
Engasertib in Hereditary Hemorrhagic Telangiectasia. ReplyHanny Al-Samkari, Damien Picard, Hans-Jurgen Mager
Haematologica|May 26, 2018
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspectiveAthena Kritharis, Hanny Al-Samkari, David J Kuter
Cancers|July 26, 2020
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer PatientsOrly Leiva, Jean M Connors, Hanny Al-Samkari
Annals of Internal Medicine|September 13, 2021
Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case ReportHanny Al-Samkari, Rebecca Karp Leaf, Katayoon Goodarzi
The New England Journal of Medicine|June 3, 2026
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. ReplyHanny Al-Samkari, Kejia Wang, Gerald A Soff
Pediatric Blood & Cancer|December 28, 2021
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trialsNardeen Ayad, Rachael F Grace, Hanny Al-Samkari
Pageof 21